Cargando…

Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas

Soft tissue sarcomas (STS) are rare and heterogeneous tumours comprising over 80 different histological subtypes. Treatment options remain limited in advanced STS with high rates of recurrence following resection of localised disease. Prognostication in clinical practice relies predominantly on hist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merry, Eve, Thway, Khin, Jones, Robin L., Huang, Paul H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935908/ https://www.ncbi.nlm.nih.gov/pubmed/33674685 http://dx.doi.org/10.1038/s41698-021-00157-4

Ejemplares similares

The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular Signalling
por: Pankova, Valeriya, et al.
Publicado: (2021)

Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas
por: Kerrison, William G. J., et al.
Publicado: (2022)

Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas
por: Noujaim, Jonathan, et al.
Publicado: (2016)

Advances in the treatment of soft tissue sarcoma: focus on eribulin
por: Koliou, Panagiotis, et al.
Publicado: (2018)

Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells
por: Thway, Khin, et al.
Publicado: (2016)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry
por: Milighetti, Martina, et al.
Publicado: (2021)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

The evolving management of epithelioid sarcoma
por: Alves, Anneke, et al.
Publicado: (2021)

The proteomic landscape of soft tissue sarcomas
por: Burns, Jessica, et al.
Publicado: (2023)

Efficacy of Eribulin in Soft Tissue Sarcomas
por: Phillips, Edward, et al.
Publicado: (2022)

Foreign Body Granulomas Induced by Intramuscular Leuprorelin Acetate Injection for Prostate Cancer: Clinical Mimics of Soft Tissue Sarcoma
por: Thway, Khin, et al.
Publicado: (2015)

Soft Tissue Myoepithelial Carcinoma Metastatic to the Cecum: Highlighting an Unusual Metastatic Pattern and the Need for Diagnostic Awareness
por: Mourtzoukou, Despoina, et al.
Publicado: (2016)

Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas
por: Napolitano, Andrea, et al.
Publicado: (2021)

Histopathological Diagnostic Discrepancies in Soft Tissue Tumours Referred to a Specialist Centre
por: Thway, Khin, et al.
Publicado: (2009)

Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary
por: Merry, Eve, et al.
Publicado: (2020)

Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib
por: Rajendra, Rajeev, et al.
Publicado: (2013)

MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas
por: Teo, Andrea York Tiang, et al.
Publicado: (2023)

Diagnostic Differences in Expert Second-Opinion Consultation Cases at a Tertiary Sarcoma Center
por: Rupani, Asha, et al.
Publicado: (2020)

Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging
por: Lou, Sha, et al.
Publicado: (2016)

Phase III Soft Tissue Sarcoma Trials: Success or Failure?
por: Lee, Alexander T. J., et al.
Publicado: (2017)

2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma
por: Frezza, Anna Maria, et al.
Publicado: (2018)

Soft Tissue Special Issue: Perivascular and Vascular Tumors of the Head and Neck
por: Flucke, Uta, et al.
Publicado: (2020)

Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?
por: Arthur, Amani, et al.
Publicado: (2022)

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study
por: Brodowicz, Thomas, et al.
Publicado: (2020)

Prognostic factors for survival in soft tissue sarcoma.
por: el-Jabbour, J. N., et al.
Publicado: (1990)

Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2011)

Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy
por: Noujaim, Jonathan, et al.
Publicado: (2015)

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
por: Desar, Ingrid M E, et al.
Publicado: (2016)

Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies
por: Caruso, Chiara, et al.
Publicado: (2020)

Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level
por: Pillozzi, Serena, et al.
Publicado: (2021)

Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma
por: Chen, Yuxiao, et al.
Publicado: (2020)

Histopathological Diagnostic Discrepancies in Soft Tissue Tumours Referred to a Specialist Centre: Reassessment in the Era of Ancillary Molecular Diagnosis
por: Thway, Khin, et al.
Publicado: (2014)

Hypoxia-Inducible Factors: Mediators of Cancer Progression; Prognostic and Therapeutic Targets in Soft Tissue Sarcomas
por: Sadri, Navid, et al.
Publicado: (2013)

Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
por: Smeland, Eivind, et al.
Publicado: (2012)

Supervised Machine-Learning Enables Segmentation and Evaluation of Heterogeneous Post-treatment Changes in Multi-Parametric MRI of Soft-Tissue Sarcoma
por: Blackledge, Matthew D., et al.
Publicado: (2019)

Radiomic Features From Diffusion-Weighted MRI of Retroperitoneal Soft-Tissue Sarcomas Are Repeatable and Exhibit Change After Radiotherapy
por: Thrussell, Imogen, et al.
Publicado: (2022)

Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas
por: Chadha, Madhumeeta, et al.
Publicado: (2022)

Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma
por: Pender, Alexandra, et al.
Publicado: (2017)

Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation
por: Hallin, Magnus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bp75rdngbc52ea7fp2f4510hom